ArticleAtherosclerosis2020

The changing landscape of lipid-lowering therapy after the new ESC/EAS guidelines for the management of dyslipidaemias: Launching the era of triple hypolipidaemic therapy in very high risk patients.

Loukianos S RallidisPubMed ↗Publisher ↗

No numbers read from the abstract.